Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Acoustic Coagulation Cuff Reduces Blood Loss

By HospiMedica International staff writers
Posted on 13 Oct 2008
A prototype ultrasound device limits blood loss and hemorrhagic shock resulting from limb injuries, saving lives in combat zones.

The deep bleeder acoustic coagulation (DBAC) cuff is designed to limit blood loss from penetrating wounds to limbs in fast and slow bleeders, significantly reducing the risk of limb loss and death resulting from irreversible hemorrhagic shock. More...
Capable of accommodating a variety of limbs ranging from the wide male thigh to the slender female arm, ultrasound technology within the cuff automatically detects the location and severity of the bleeding within the limb. This triggers therapeutic ultrasound elements within the cuff to emit and focus high-power energy toward the bleeding sites, speeding coagulation, and halting bleeding at the injury. The device is intended for use by minimally trained operators, curtailing bleeding in a very short time with automatic treatment and power shut-off. The cuff is being designed with field use in mind, requiring a compact, lightweight form with highly integrated electronics. The DBAC is being developed by Siemens Healthcare (Malvern, PA, USA) under an exclusive contract with the U.S. Defense Advanced Research Projects Agency (DARPA, Arlington, VA, USA). Siemens Healthcare will partner with Siemens Corporate Research (SCR, Princeton, NJ, USA), the center for industrial and medical ultrasound at the University of Washington (UW, Seattle, USA), and The Institute for Preclinical Studies (TIPS) at the Texas A&M University (College Station, USA) to develop a prototype within 18 months.

"We are very excited to leverage advanced technologies of Siemens ultrasound such as real-time volumetric imaging and Silicon transducers to realize DARPA's vision for saving lives on the battlefield,” said Richard Chiao, vice president of Siemens Healthcare's ultrasound innovation group. "We believe technologies developed for this new therapeutic application of ultrasound will also benefit civilian care in the future.”

"The challenge of applying our extensive animal modeling expertise to develop this potentially life-saving technology is exciting,” said Matthew W. Miller, DVM, a professor of cardiology and associate director for research at TIPS. "The opportunity to work closely with talented colleagues at SCR and UW will ensure that the likelihood of success is maximized.”

Related Links:
Defense Advanced Research Projects Agency
Siemens Healthcare
Siemens Corporate Research
University of Washington
Texas A&M University


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.